At the time of writing, Arvinas Inc [ARVN] stock is trading at $6.64, up 1.68%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ARVN shares have gain 5.56% over the last week, with a monthly amount drifted -24.11%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arvinas Inc [NASDAQ: ARVN] stock has seen the most recent analyst activity on May 05, 2025, when Truist downgraded its rating to a Hold but kept the price target unchanged to $11 for it. Previously, TD Cowen downgraded its rating to Hold on May 02, 2025. On May 02, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $10 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $15 on March 13, 2025. Wedbush downgraded its rating to a Neutral and reduced its price target to $12 on March 12, 2025. Oppenheimer downgraded its rating to Perform for this stock on March 11, 2025. In a note dated December 10, 2024, BTIG Research initiated an Buy rating and provided a target price of $69 on this stock.
For the past year, the stock price of Arvinas Inc fluctuated between $5.90 and $37.38. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Arvinas Inc [NASDAQ: ARVN] shares were valued at $6.64 at the most recent close of the market. An investor can expect a potential return of 156.02% based on the average ARVN price forecast.
Analyzing the ARVN fundamentals
According to Arvinas Inc [NASDAQ:ARVN], the company’s sales were 161.00M for trailing twelve months, which represents an 646.25% jump. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.08 and Total Capital is -0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Arvinas Inc [NASDAQ:ARVN] has a current ratio of 4.58. Also, the Quick Ratio is 4.58, while the Cash Ratio stands at 0.38. Considering the valuation of this stock, the price to sales ratio is 3.01, the price to book ratio is 0.73.
Transactions by insiders
Recent insider trading involved Berkowitz Noah, Chief Medical Officer, that happened on Mar 18 ’25 when 8658.0 shares were sold. Officer, Noah Berkowitz completed a deal on Mar 18 ’25 to buy 8658.0 shares. Meanwhile, Chief Accounting Officer Loomis David K sold 1214.0 shares on Feb 24 ’25.
